Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: GRIFOLS THERAPEUTICS LLC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-09-27 to 2025-09-29
Current total value of award: $613200
Description: GRIFOLS THERAPEUTICS LLC- OCULAR SURFACE IMMUNOGLOBULIN IN THE MANAGEMENT OF VESICANT AGENTS INJURY